Nextgen Biomed Ltd

Tel Aviv Stock Exchange:NXGN.TA

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🧴 Personal Care

💊 Pharmaceuticals

Location

Israel

Market Cap

USD 1.11 M

Share Price

USD 0.15

Avg Daily Volume

42,077

Change (1 day)

2.79%

Change (1 year)

-44.01%

Change (YTD)

-8.96%

Nextgen Biomed Ltd Total Assets for the year ending December 31, 2024

Nextgen Biomed Ltd Total Assets is NA for the year ending December 31, 2024. Total assets are the total value of all assets owned by a company, representing its resources.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Total Assets	Accounts Payable	Short-Term Debt	Long-Term Debt

Tel Aviv Stock Exchange: NXGN.TA

Nextgen Biomed Ltd

CEO	Mr. Harel Hershtik
IPO Date	Aug. 12, 2002
Location	Israel
Headquarters	132 Azrieli Towers Round Building
Employees	3
Sector	🏥 Health Care
Industries Cosmetics 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🧴 Personal Care 💊 Pharmaceuticals

Description

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

Similar companies

Bayer AG

USD 30.75

1.24%

Roivant Sciences Ltd.

USD 11.54

0.35%

ALK-Abelló A/S

USD 28.60

0.69%

PharmaResearch Co., Ltd.

USD 350.44

0.79%

Bloomage BioTechnology Corporation Limited

USD 7.20

2.04%

J. B. Chemicals & Pharmaceuticals Limited

USD 20.96

0.15%

Joincare Pharmaceutical Group Industry Co.,Ltd.

USD 1.53

1.11%

Almirall, S.A.

USD 12.47

1.42%

Organon & Co.

USD 9.95

1.53%

Bausch Health Companies Inc.

USD 6.18

1.32%

Tarsus Pharmaceuticals, Inc.

USD 41.40

1.97%

Eli Lilly and Company

USD 778.08

0.97%

Johnson & Johnson

USD 152.19

0.57%

Novo Nordisk A/S

USD 70.31

0.79%

AbbVie Inc.

USD 185.55

0.97%

Roche Holding AG

USD 344.94

1.55%

Abbott Laboratories

USD 138.08

3.62%

Novartis AG

USD 118.40

1.48%

AstraZeneca PLC

USD 140.65

-0.17%

Merck & Co., Inc.

USD 80.32

0.20%

Amgen Inc.

USD 277.49

1.85%

Pfizer Inc.

USD 24.31

1.17%

Gilead Sciences, Inc.

USD 107.20

0.95%

Sanofi

USD 97.12

1.00%

Vertex Pharmaceuticals Incorporated

USD 450.27

1.52%

Bristol-Myers Squibb Company

USD 47.03

0.23%

Chugai Pharmaceutical Co., Ltd.

USD 51.89

-0.16%

GSK plc

USD 19.19

1.18%

CSL Limited

USD 155.39

-0.72%

Cencora, Inc.

USD 294.12

0.34%

Regeneron Pharmaceuticals, Inc.

USD 522.27

2.02%

MERCK Kommanditgesellschaft auf Aktien

USD 129.67

2.44%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.27

0.47%

Haleon plc

USD 5.21

0.36%

Takeda Pharmaceutical Company Limited

USD 30.01

-0.31%

Reckitt Benckiser Group plc

USD 68.77

0.72%

Daiichi Sankyo Company, Limited

USD 23.20

-0.02%

Alnylam Pharmaceuticals, Inc.

USD 325.00

3.79%

UCB SA

USD 191.95

0.86%

GE HealthCare Technologies Inc.

USD 71.98

1.15%

WuXi AppTec Co., Ltd.

USD 9.97

1.20%

Celltrion, Inc.

USD 117.23

-0.65%

Otsuka Holdings Co., Ltd.

USD 48.63

-0.34%

Hansoh Pharmaceutical Group Company Limited

USD 3.72

-0.31%

Laboratory Corporation of America Holdings

USD 262.53

0.57%

Divi's Laboratories Limited

USD 76.67

0.37%

Teva Pharmaceutical Industries Limited

USD 17.11

0.06%

Insmed Incorporated

USD 105.90

0.46%

Royalty Pharma plc

USD 36.14

2.09%

StockViz Staff

June 25, 2025

Any question? Send us an email